Platform Technology

Regenerative medicine holds tremendous promise to cure a variety of disease conditions with no satisfactory standard-of-care today. It is not enough to 'manage' the disease through short-term solutions, which carry the risk of recurrence and eventual progression to an acute condition.

Regrow's proprietary cell-based platform technology provides a biological, curative and chronic reversible clinical benefit to several diseases. We have devised a three-pronged platform technology consisting of a biological agent, biomechanical carrier and delivery system that allows targeted and localized repair of injured or degenerated tissue. Our products are highly characterized with strict in-process controls keeping the safety of the patients in mind.

Regrow is actively working on augmenting the use of the cell-based platform for a multitude of diseases indications spanning musculoskeletal disorders, urology, oncology, and soft tissue injuries.